John F. Clifford, President and CEO

Jack joined ProCyte in August 1996 as a Director and as President and Chief Executive Officer. On August 25, 1999, Mr. Clifford was elected Chairman of the Board. Before joining ProCyte, from 1994 to 1996, Mr. Clifford was the President of Orthofix, Inc. and American Medical Electronics, Dallas-area healthcare companies in the orthopedic market. From 1989 to 1994, Mr. Clifford was employed by American Cyanamid’s Davis and Geck Division, a medical device company, initially as the Vice President of Sales and Marketing and later as Division President. From 1964 to 1989 Mr. Clifford held various sales and marketing positions in Ethicon Inc., and Iolab Corp, both Johnson & Johnson companies. Mr. Clifford holds a B.S. in economics from Villanova University and an M.B.A. in finance from Drexel University.

Robert joined ProCyte in October 2002 as Chief Financial Officer and was elected Corporate Secretary in December 2002. Before joining ProCyte, Mr. Benson was Chief Financial Officer and Secretary for Appliant, Inc., a private software company. Prior to that, he served as Chief Financial Officer, and subsequently Chief Operating Officer, of Data Critical Corporation, a medical products company that was subsequently acquired by GE Medical. Mr. Benson has also been Chief Financial Officer for Stellar One Corporation and Special Devices, Inc. Benson began his career with KPMG Peat Marwick and earned his Bachelor of Science in Accounting, cum laud, from California State University, Northridge.

Robin L. Carmichael, Vice President of Marketing

Robin joined ProCyte in 1993 in the clinical research department. From 1996 to 1997, she worked in our marketing department as a Product Manager. In 1997 Ms. Carmichael was promoted to Director of Marketing and was subsequently appointed Vice President of Marketing in 1998. Ms. Carmichael has over 20 years of sales and marketing experience in the healthcare industry, having held various sales management and marketing positions in the health and medical industries, including six years at Baxter Healthcare. Ms. Carmichael holds a B.S. in nursing from Seattle University and attended the UCLA Anderson Graduate School of Executive Management.

John M. Hammer, Member of the Board of Directors

John was initially elected a Director of ProCyte in 2000. Mr. Hammer is currently serving as President of JMH Enterprises, a consulting group specializing in the packaged goods industry and particularly private and small cap business, since December 2002.  He was Chief Executive Officer of Hair Systems, Inc. from 2001 to 2002, President of JMH Enterprises from 1997 to 2001, President of Revlon Professional Products in North America from 1995 to 1997, and President of Redken Laboratories from 1990 to 1995.  He is chairman of the Compensation Committee and a member of the Audit and Nominating Committees. Mr. Hammer received a J.D. from Fordham University School of Law in 1973.

Dr. Leavitt was initially elected a director of ProCyte in April 1998. Since 1990 he has served as the Chairman, Chief Executive Officer and Medical Director of Leavitt Medical Group, a group of nationwide clinics that perform hair restoration, dermatology and cosmetic surgery procedures. Dr. Leavitt has served as Vice President of the American Board of Hair Restoration since 1997 and is a past President of the American College of Dermatology. He is the former Chairman of the World Association of Hair Restoration Surgeons and an advisor and trustee for the American Academy of Aesthetic & Restorative Surgery. Dr. Leavitt has written chapters in numerous medical textbooks, authored articles in numerous medical journals, and served as editor for several editions of the International Journal of Cosmetic Surgery. Dr. Leavitt is a member of the Compensation and Nominating Committees. Dr. Leavitt is a graduate of the University of Michigan in Premed and Michigan State University College of Osteopathic Medicine and is Board-Certified in Dermatology.

Bob was initially elected a Director of ProCyte in 1994, and served as Secretary from August 2000 to December 2002. He has been a partner in the legal services firm of Squire Sanders and Dempsey since 1972. Mr. Patterson is a director of Acuity Ventures, Capital Pacific Development Inc., T.C. Technology US L.P. Peninsula Equity Partners, Net Vault, Inc., LEDA Corporation, Sumida Corporation, and California Airlines. Mr. Patterson is also serving as the President and a director of Transierra Corporation, Dermozyme Corporation, and Synzyme Technology LLC. He is Chairman of our Audit Committee and is a member of our Compensation and Nominating Committees. Mr. Patterson completed the Executive Program at the Stanford Graduate School of Business in 1986; he obtained his law degree from Stanford Law School and holds a B.A. in Physics from the University of California at Los Angeles. During the fall of 1998 he served as the Inaugural Fellow of the Tuck Center Private Equity at Dartmouth College.